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 Abstract 
 
Introduction: Coronary heart disease (CHD) is one of the main death causes in the world. 
Therefore, it is necessary to identify the psychological disorders in these patients and to apply the 
necessary interventions to reduce them. The purpose of the present research was to examine the 
effectiveness of transdiagnostic treatment on health locus of control and emotional regulation in 
patients with CHD.  
Methods: This research was a quasi-experimental one with the plan of pretest posttest control 
group. The statistical population included all patients with coronary heart disease 40-65 years old 
who were treated in Kasra hospital of Tehran in 2019. The sample included 90 patients assigned to 
the two groups experimental and control group randomly. Data were collected using the 
Multidimensional Health Locus of Control Scale and Emotional Regulation Scale. The data were 
analyzed using the methods of multivariate analysis of covariance (MANCOVA).  
Results: The result showed that the transdiagnostic therapy significantly increases the internal 
health locus of control and emotional regulation in the experimental group (p<0.01).  
Discussion: This finding has important implications as regards the education and mental health of 
patients with coronary heart disease. Based on the results, it is necessary to pay more attention to 
two variables health locus of control and emotional regulation in the design of interventions to 
reduce the psychological problems
,
 patients with CHD. 
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      Introduction 
     Coronary heart disease (CHD) is one of 
the main death causes in the world. One in five 
people dies because of this disease (1). In spite 
of medical advances, CHD is one of the most 
prevalent chronic diseases and one of the death 
causes in Iran. Therefore, heart surgeries 
constitute about 60% of surgeries in the 
country (2). CHD prevalence is increasing due 
to population growth and aging all over the 
world (3). Regarding the high prevalence of 
CHD, the World Health Organization (WHO) 
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has sent one of its goals as achieving a 25% 
decrease in heart attack-caused deaths by the 
year 2015 (4). Evidence suggests that 
traditional factors only predict half of the CHD 
variance. Consequently, researchers have 
become interested in investigating the 
psychosocial risk factors of CHD (5). 
According to studies, patients with CHD 
report serious psychological problems, such as 
high levels of anxiety, depression, and self-
criticism, which can affect patients' health (6). 
In fact, in addition to biological factors, 
psychological factors are also effective in all 
heart diseases. The health locus of control is 
one of these effective psychological factors 
(7).  
Health locus of control defined as individual 
beliefs based on past experiences in health 
issues and having external or internal control 
over them could affect health (8). People who 
are more responsible about their health and 
believe that they control their health 
themselves become more involved in health-
related behaviors and these behaviors have 
positive mental effects on them (9). Those who 
believe that other people or chance are 
responsible for their health have an external 
locus of control; it will lead to the person’s 
loneliness, inability, and unsuccessful fight 
against diseases (10,11). The results of the 
research suggest that people with an internal 
health locus of control have a health-
promoting lifestyle, higher physical and 
psychological health, and less health-risk 
behaviors such as alcohol consumption, 
intense sport, aggression, etc (12).  
Emotion regulation is another variable 
involved in this disorder because negative 
emotions play a major role in the incidence 
and exacerbation of heart disease. The findings 
of numerous studies show that emotions are 
effective in triggering, exacerbating, and 
adjustment to chronic illnesses. (13). 
Emotional regulation is a process by which 
people change the experience or expression of 
their emotions. It can be used to make people 
feel better or to achieve a variety of both 
personal and interpersonal goals (14,15). The 
results of numerous studies indicate 
difficulties in regulating emotions in 
cardiovascular patients. For example, one 
study showed that poor emotion regulation 
strategies are an important factor in the 
development of heart disease (16). Besharat 
and Ramesh (17) in their study showed that 
difficulty in emotion regulation was associated 
with worry and anger rumination in 
cardiovascular patients. 
Regarding the results of the studies and the 
approved effectiveness of psychological 
factors in the occurrence of this disease, 
psychological interventions seem to be 
necessary for improving psychological health 
and decreasing the symptoms in CHD patients. 
Transdiagnostic treatment is one of the new 
treatments developed in recent years among 
the transformations of cognitive-behavioral 
therapy opposed to specific treatments for 
emotional disorders (18). According to meta-
analysis studies, this treatment has higher 
effectiveness compared with traditional 
methods of cognitive-behavioral therapy 
(18,19). The transdiagnostic approach focuses 
on identifying the common and core 
maladaptive temperamental, psychological, 
cognitive, emotional, interpersonal and 
behavioral processes that underpin a broad 
array of diagnostic presentations (20) and 
targeting these factors in treatment (21). This 
approach which mainly emphasizes cognitive 
and behavioral processes attempts to teach 
people how to face with their unfavorable 
emotions and respond to their emotions in a 
more adaptive manner; so that they can 
decrease the intensity and occurrence of 
emotional habits by regulating them, decrease 
traumas, and increase efficiency (20).  
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Researchers have proved the effectiveness of 
this treatment on emotional regulation and the 
decrease of emotional problems in 
psychological disorders such as anxiety and 
mood disorders (19,22). However, few types 
of research have investigated the effectiveness 
of transdiagnostic treatment in patients with 
CHD. Researchers in a study (23) aimed to 
investigate the effectiveness of emotional 
regulation intervention on cognitive emotion 
regulation strategies and alexithymia in CHD 
patients, found this intervention is effective in 
reducing maladaptive cognitive emotion 
regulation strategy and alexithymia and 
enhancing adaptive cognitive emotion 
regulation strategies. In another study aimed at 
investigating the effect of transdiagnostic 
cognitive-behavioral treatment on anxiety 
disorders, it was found that transdiagnostic 
cognitive-behavioral treatment can improve 
the function and efficacy of patients with 
anxiety disorders (24). Maddahi et al. (25) 
performed a study aimed at investigating the 
effectiveness of integrated transdiagnostic 
treatment on cognitive emotion regulation in 
patients with CHD. They showed that this 
treatment is effective in cognitive emotion 
regulation and promotes the patients’ quality 
of life. Rideout et al. (26) conducted a study 
aimed at investigating health locus of control 
in heart transplant patients. They showed that 
patients with an internal locus of control had a 
better process of rehabilitation and 
improvement, but patients with an external 
health locus of control gained poor results of 
improvement process.  
According to the above statements, 
psychological problems among CHD patients, 
and the effect of the interventions performed 
in the country, the present research is aimed at 
the evaluation of the effectiveness of 
transdiagnostic treatment on health locus of 
control and emotional regulation in patients 
with CHD. 
 
   Method  
  This research has been conducted by a semi-
experimental method with pretest-posttest 
design and control group. In this research, 
treatment methods have been considered as 
independent variables at two levels 
(transdiagnostic treatment and no 
intervention), and health locus of control and 
emotional regulation have been considered as 
dependent variables. The research population 
includes all the patients with coronary heart 
diseases at the age of 40-65 years who have 
been under treatment in Kasra Hospital of 
Tehran in 2019. The sample includes 90 
patients with CHD who have been selected by 
convenience sampling and randomly assigned 
to experimental and control groups. The 
sample size was determined by using the 
following formula. As the population was 
specific and limited, the sample size was 
obtained by the following formula with an 
accuracy of 5% and a confidence level of 95%.  
 
The inclusion criteria included: the patient’s 
willingness to participate in the study, female 
and male patients with coronary heart diseases 
at the age of 40-65 years, diagnosis of the 
patient’s disease by a specialist, 2 years past 
from diagnosis of the disease, and the patients 
with the education level of at least a middle 
school degree. The exclusion criteria included: 
patients not collaborating with the therapist, 
patients’ unwillingness to continue 
participating in the study, patients with a 
background of mental illnesses and intellectual 
disability, patients simultaneously receiving 
psychological and psychiatric interventions, 
chronic physical illnesses, drug addiction or 
abuse.  
Data collection was done by using the 
following tools: 
- Multidimensional health locus of 
control (MHLC): Health locus of control 
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questionnaire was designed by Wallston (10). 
This questionnaire includes three components 
of internal locus of control, powerful others 
locus of control, and chance locus of control. 
Health locus of control questionnaire includes 
18 items and each item consists of six choices 
ranging from quite agree (score 1) to quite 
disagree (score 6). Every individual’s score 
ranges from 6 to 36 for each subscale that is 
evaluated separately. Six out of the 18 items 
measure people’s beliefs about internal health 
locus of control, and the remaining 12 items 
evaluate the people in terms of the effect of 
factors such as chance, powerful others, 
physicians, etc. on the person’s health; these 
factors represent for an external health locus of 
control (10). Moshki et al. (27) first evaluated 
the reliability and validity of this tool, 
translated, and localized that in Iran. They 
reported acceptable reliability and validity for 
this questionnaire. Also, they reported the 
Cronbach’s alpha values of 0.70, 0.75, and 
0.69 respectively for I, P, and C components.  
- Emotion regulation scale: This scale 
was developed by Gross and John (23). It has 
10 items including two subscales of 
reappraisal (6 items) and suppression (4 
items). The answers are based on Likert (7-
degree) scale ranging from quite disagree (1) 
to quite agree (7). The Cronbach’s alpha 
coefficient was reported as 0.79 for reappraisal 
and 0.73 for suppression; the retest reliability 
for the total scale was reported as 0.69 after 
three months (28). The correlation coefficient 
of reappraisal was reported as 0.24 with 
positive emotions and -0.14 with negative 
emotions; the correlation coefficient of 
suppression was reported as -0.15 with 
positive emotions and 0.04 with negative 
emotions (28). The Persian version of Gross 
and John’s emotional regulation questionnaire 
has been standardized by Hasani (29). In this 
research, the scale reliability has been 
determined by internal consistency (with 
Cronbach’s alpha ranging in 0.60-0.81) and an 
acceptable validity of the scale has been 
reported based on principal component 
analysis by using varimax rotation, the 
correlation between the two subscales 
(r=0.13), and criterion validity.  
- Transdiagnostic treatment: This 
approach is based on emotional experience and 
(positive or negative) emotional response. It 
attempts to teach people how to face with their 
unfavorable emotions and respond to their 
emotions in a more adaptive manner (18,20). 
Transdiagnostic group therapy is a treatment 
protocol developed by Barlow et al. (18); the 
program includes eleven 90-min sessions held 
once a week.  
 
        Table1. Summary of transdiagnostic group therapy intervention sessions  
Sessi
on 
Content 
1 The group members become familiar with each other and participate in relationship therapy; the members 
become familiar with the research subject and they get the primary explanations; the problem is conceptualized; 
the psychological symptoms of heart diseases, pharmacological and non-pharmacological treatments are 
specified; the questionnaires are answered; the pretest is performed; treatment contract is entered into, and the 
general plan of treatment sessions are addressed.  
2 Psycho-education about the nature of emotions and distinguishing between emotions and thoughts; this session 
is aimed at increasing the person’s awareness of emotional triggers and responses to unfavorable emotional 
experiences.  
3 Increasing the instantaneous and non-judgmental awareness of emotional experiences; orientation to the present 
moment; provocation of positive and negative emotions; avoiding emotional suppression; provocation of 
emotions by using mindfulness and emotion induction. 
4 Recognition and revision in thinking patterns with the goal of creating flexibility in thinking.  
5,6 Recognition of behaviors affected by emotion; creating inconsistent behaviors and emotional exposure; 
education of detection of the contradictory effect of emotional suppression and control; recognition and 
prevention of emotional avoidance patterns; education of awareness of physical emotions and bearing them.  
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7,8 Emotional exposure; introduction of emotional arousal logic; recognition of the effect of emotional experiences 
on physical emotion.  
9 Repeated exposure and the role of habituation; prevention of situational avoidance; creation of fear-avoidance 
hierarchy and providing the possibility of emotional exposure; clinical actions for exposure to exciting 
situations and recognition of the response to these emotions.  
10,11 Prevention of recurrence by focusing on prevention of emotional avoidance and emotional tolerance; 
summarizing the contents and performing the posttest.  
 
In this research first, the theoretical 
foundations were collected by library method. 
After getting permission from the university 
and necessary actions were taken for 
collaborating with Kasra Hosptial of Tehran 
and performing the interventions. Then, study 
sample was selected by available method and 
randomly assigned to experimental and control 
groups. The subjects were made aware of the 
research goals and asked to participate in the 
treatment program. In group therapy, the 
treatment sessions included eleven 90-min 
sessions held once a week in the hospital. 
Before and after the intervention, the two 
groups completed the questionnaires. Data 
were analyzed in SPSS 21 software.  
 
   Results 
   The results of the research showed that the 
mean (and standard deviation) of the age of 
patients affected by coronary heart disease 
were respectively 56.38 and 7.10 in the 
experimental group and 55.09 and 6.88 in the 
control group. In the experimental group, 
84.4% (38 people) were married and 15.6% (7 
people) were single. In the control group, 
77.8% (35 people) were married and 22.2% 
(10 people) were single. 
Table 1 presents the mean and standard 
deviation of quality of life for patients affected 
by macular degeneration in control and 
experimental groups based on the pretest and 
posttest results.  
Table 2: Mean and standard deviation of depression scores of control and experiment groups in pretest and posttest 
Control 
group  
 Experimental 
group  
  Quality of life  
SD Mean SD Mean   
      
2.57 15. 29 2.46 14.95 Pretest  Internal locus of 
control  
3.23 14.44 2.16 20.15 Posttest   
1.65 18.71 2.32 18.84 Pretest  Powerful others locus 
of control  
1.45 17.55 1.92 15.20 Posttest   
1.67 17.60 2.26 17.73 Pretest  Chance locus of 
control  
1.41 16.49 1.92 14.22 Posttest   
3.09 21.91 2.99 21.87 Pretest  Emotional reappraisal  
3.67 20.09 3.73 23.98 Posttest   
0.84 19.44 0.75 19.58 Pretest  Emotional 
suppression  
0.87 19.08 0.65 16.82 Posttest   
 
As seen in the table, there is an obvious 
difference between the mean posttest scores of 
health locus of control and emotional 
regulation in the control and experimental 
groups; in the experimental group, the mean 
scores of internal health locus of control and 
emotional reappraisal in posttest are higher 
than the scores of the pretest. The mean scores 
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of powerful others locus of control, chance 
locus of control, and emotional suppression in 
the posttest are lower than the scores of 
pretest.  
In order to observe the assumptions of 
parametric tests, Box and Levene’s tests were 
used before using the parametric test of 
multivariate analysis of covariance. The results 
of the Box test were not significant for any of 
the variables; based on this test, the 
presumption of homogeneity of 
variance/covariance matrixes have been well 
observed (Box=17.296, F=2.78, P=0.051). 
According to the results of Levene’s test, the 
presumption of equality of intergroup 
variances has been observed for posttest and 
its insignificant results for all variables 
(p>0.05). Therefore, multivariate analysis of 
covariance can be done. The results of Wilks 
Lambda showed that there is a significant 
difference between the posttest of the studied 
groups in terms of at least one of the 
dependent variables (Wilks Lambda= 0.218, 
F=99.37, P ˂ 0.001). According to the results 
of eta-squared, it was found that the difference 
between the two groups is significant 
regarding the dependent variables and this 
difference in posttest is 78% based on Wilks 
Lambda (eta squared=0.782); i.e. 78% of the 
variance is related to the difference between 
the two groups which results from the mutual 
effect of dependent variable of health locus of 
control.  
              
              Table 3. The results of the analysis of covariance  
Eta 
squared 
F MS Df SS Source of 
change 
Variable  
       
0.620 138.61 401.32 1 401.32 Pretest Internal locus of control  
0.766 278.37 805.98 1 805.98 Group  
  2.895 85 246.10 Error  
0.004 0.32 0.95 1 0.95 Pretest Powerful others locus 
of control  
0.338 43.46 127.69 1 127.69 Group  
  2/94 85 249.74 Error  
0.013 1.09 3.08 1 3.08 Pretest Chance locus of control  
0.330 41.83 118.57 1 118.57 Group  
  2.83 85 240.94 Error  
 
As presented in table 3, with the controlled 
effect of pretest, there is a significant 
difference between the posttest results of 
experimental and control groups in terms of 
the mean scores of internal locus of control 
(F=278.37), powerful others locus of control 
(F=43.46), and chance locus of control 
(F=41.83) (P˂ 0.001). In other words, in 
posttest of the experimental group, 
transdiagnostic group therapy has significantly 
increased internal health locus of control in 
patients with coronary heart disease. Also, in 
posttest of the experimental group, 
transdiagnostic group therapy has significantly 
decreased powerful others locus of control and 
chance locus of control in patients with 
coronary heart disease. 
In order to observe the assumptions of 
parametric tests, Box and Levene’s tests were 
used before using the parametric test of 
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multivariate analysis of covariance. The results 
of the Box test were not significant for any of 
the variables; based on this test, the 
presumption of homogeneity of 
variance/covariance matrixes have been 
accurately observed (Box=4.086, F=1.328, 
P=0.263). According to the results of Levene’s 
test presented in Table 4, the presumption of 
equality of intergroup variances has been 
observed for posttest and its insignificant 
results for all variables. So, multivariate 
analysis of covariance can be done. The results 
of Wilks Lambda showed that there is a 
significant difference between the posttest of 
the studied groups in terms of at least one of 
the dependent variables (Wilks Lambda= 
0.180, F=1.931, P ˂ 0.001). According to the 
results of eta-squared, it was found that the 
difference between the two groups is 
significant regarding the dependent variables 
and this difference in posttest is 82% based on 
Wilks Lambda (eta squared=0.820); i.e. 82% 
of the variance is related to the difference 
between the two groups which results from the 
mutual effect of dependent variable of 
emotional regulation. 
       
               
                 Table4. The results of the analysis of covariance  
Eta 
squared  
F MS Df SS Source of 
change  
Variable  
0.203 21.90 243.87 1 243.87 Pretest  Emotional reappraisal   
0.266 31.16 346.91 1 346.91 Group    
  11.13 86 957.55 Error   
0.367 56.61 19.67 1 19.670 Pretest  Emotional suppression   
0.805 354.57 123.20 1 123.20 Group    
  0.35 29.88       86 Error   
      
As presented in table 4, with the controlled 
effect of the pretest, there is a significant 
difference between the posttest results of 
experimental and control groups in terms of 
the mean scores of emotional reappraisal 
(F=31.16) and emotional suppression 
(F=354.57) (P ˂ 0.001). In other words, in 
posttest of the experimental group, 
transdiagnostic group therapy has significantly 
increased emotional reappraisal in patients 
with coronary heart disease. Also, in posttest 
of the experimental group, transdiagnostic 
group therapy has significantly decreased 
emotional suppression in patients with 
coronary heart disease. 
 
    Discussion and Conclusion  
   The present research has been aimed at 
determining the effect of transdiagnostic 
treatment on health locus of control and 
emotional regulation in CHD patients with 
CHD. According to the findings, 
transdiagnostic treatment is effective in health 
locus of control in patients with CHD. 
Transdiagnostic group therapy is significantly 
effective in increasing internal health locus of 
control and decreasing powerful others locus 
of control and chance locus of control in 
patients with CHD. 
Many studies have investigated the 
relationship between health locus of control 
and the promotion of people’s health (8). The 
results of studies suggest that people with an 
internal health locus of control have a health-
promoting lifestyle, higher physical and 
psychological health, and less health- risk 
behaviors such as alcohol consumption, 
intense sport, aggression, etc (26,27). Rideout 
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and et al. (26) showed that patients with an 
internal locus of control had a better process of 
rehabilitation and improvement, but patients 
with an external health locus of control had 
poor results of improvement process. 
However, in spite of the available studies, 
there is a large research gap in the area of 
effectiveness of transdiagnostic treatment on 
health locus of control in patients with CHD. 
Based on this approach, emotional experiences 
play the main role in occurrence and 
continuation of emotional disorders. This 
treatment helps people how to face with their 
unfavorable emotions and respond to their 
emotions in a more adaptive manner. This 
approach emphasizes changing emotional 
regulation habits to reduce the frequency and 
severity of maladaptive emotional habits, 
reduce injury, and increase performance. The 
dynamic interaction between thoughts, 
feelings, and behaviors and their role in 
emotional experience is addressed in all 
transdiagnostic approaches (19,20). In fact, 
this approach enhances cognitive and 
behavioral control in the individual by 
interacting with thoughts, feelings, and 
behaviors. Improving cognitive and behavioral 
control, in turn, leads to the use of thought and 
practice processes to modulate the effects of 
stress in patients. 
As another explanation, it can be stated that 
this treatment helps the patients to have a 
better understanding of interactions between 
the thoughts, emotions, and behaviors in 
creating their emotional experiences. This 
approach helps them respond more 
consciously and realistically rather than 
engaging in their own emotional responses. It 
also helps patients become more responsible 
for their own health and believe that they can 
control their own health. As a result, patients 
will be more responsible for their health and 
believe that they control their health 
themselves. Therefore, they acquire 
“emotional awareness” skills. This skill 
emphasizes non-judgmental awareness and 
focusing on the present moment during 
emotional experiences (26).  Finally, by 
emphasizing the increase of cognitive 
flexibility and negative assessment challenge, 
this treatment seeks for increasing people’s 
awareness of cognitive errors and cognitive 
flexibility. According to research results, 
cognitive control reduces the focus on external 
health control, people believe they can control 
their own health, and thus become more 
involved in health behaviors and has positive 
psychological and behavioral effects (10,11). 
Nafradi et al. (12) indicated that those who 
believe that other people or chance are 
responsible for their health will face 
loneliness, inability, and failure in fighting 
diseases.  
According to the research findings, 
transdiagnostic treatment is effective in 
emotional regulation in patients with CHD. 
Transdiagnostic group therapy had 
significantly increased emotional regulation in 
patients with CHD. In other words, 
transdiagnostic group therapy has significantly 
increased emotional reappraisal and decreased 
emotional suppression in patients with CHD. 
The results of the research performed by 
Bahremand et al. (16) are consistent with the 
findings of the present study. They showed 
that poor cognitive emotion regulation 
strategies are considered an important factor 
development of heart diseases. Roberge et al. 
(24) showed that transdiagnostic treatment is 
effective in cognitive emotion regulation and 
promotes the patients’ quality of life. 
Researchers have proved the effectiveness of 
this method on emotional regulation and 
reducing emotional problems in psychological 
disorders such as anxiety and mood disorders 
(20,22,24). To explain this finding, it can be 
stated that the main assumption of the 
treatment is that patients with emotional 
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disorders employ maladaptive emotion 
regulation strategies and they try to avoid 
unfavorable emotions or decrease their 
intensity. These efforts lead to a negative 
result and endurance of their symptoms. 
Therefore, transdiagnostic is an emotion-based 
treatment; i.e. the treatment has been 
developed in such a manner that it teaches the 
patients how to face their unfavorable 
emotions, experience, and respond to them in a 
more adaptive manner. The goal of this 
treatment is to decrease the intensity and 
occurrence of maladaptive emotional 
experiences and improve the patients’ function 
by modifying emotion regulation habits. 
Although the goal is improvement, 
transdiagnostic treatment is not aimed at 
eliminating unfavorable emotions; rather, it 
emphasizes returning the emotions to an 
efficient level; so that inefficient emotions 
become adaptive and helpful (20). By 
adjusting emotion regulation habits, 
transdiagnostic treatment decreases the 
intensity and occurrence of emotional habits, 
decreases traumas, promotes the function, and 
helps the patients to learn how to face their 
unfavorable emotions and respond to them in a 
more adaptive manner. In this approach, there 
is a dynamic interaction between the thoughts, 
emotions, and behaviors; each of them plays 
an effective role in emotional experiences 
(18). As another explanation, it can be stated 
that this integrated protocol changes cognitive 
reappraisal by affecting emotional processing. 
Reduced temperament leads to decreased 
thinking styles and inefficient reappraisal, 
which it finally leads to decreased emotional 
suppression, improvement of general function 
and the patients’ quality of life (18). 
Therefore, it can be concluded that prevention 
of emotional avoidance and exposure to 
emotional symptoms, participating in valuable 
activities, psychological inflexibility, and 
emotional awareness are necessary 
components of psychological health in patients 
with coronary heart disease. These 
components can be achieved by 
transdiagnostic treatment and they improve 
emotion regulation in the person (30,31).  
One of the limitations of the present study is 
that the research has investigated the patients 
with CHD at the age of 40-65 years in Kasra 
Hospital of Tehran in 2019. Therefore, there is 
a constraint regarding the possibility of 
generalizing the results. The other constraint 
of the research is the lack of follow up for 
determining the exact condition of patients 
exposed to long term interventions. 
Furthermore, sampling method and the mere 
use of questionnaire has been another 
constraint. The results of this research are 
considered as important implications of 
education and promotion of mental health in 
patients affected by coronary heart disease.  
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